Almotriptan

Migraine medication for adolescents

key word:

Migraine adolescents

Category:

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strive•s to build a large health industry finance platform company integrating pharmaceutical, intelligent• medical, bio pharmaceutical R&D, industrial productπion and sales.

The chemical reactions involved in the existing products in¶clude Foucault reaction, nitration reaction, sulfonaΩtion reaction, hydrogenation reaction, fluorination $reaction, chlorination reaction, bromination reaction, diazotization reaction, f✔ormat reaction, etc.

Migraine medication for adolescents

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibito₽r developed by Merck. In October 2006, Sitagliptin phosphate Januvλia was approved by FDA as the first DPP4 inhibitor for> the treatment of type ⅱ diabetes mellitus. The characteristics of this drug are t↑hat it can stimulate insulin secretion while reducing hunger without cau​sing weight gain. Hypoglycemia and edema will not occur, and it is suitable for diabetic pat ients with poor blood glucose control and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech phar♣maceutical enterprise that is market-oriented and realizes industrial developm£ent through R&D innovation and technology transformation.♠

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen γis one of the most important products for the treat​ment of arthritis. It is well tolerated and has a low incidence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotriene recep↕tor antagonists. In clinical application, it has good therapeutic  effect on atopic asthma and other types of bronchiγal asthma, and the market prospect is huge. In the majβor category of asthma drugs, leukotriene receptor antagonists have th★e fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharma ceutical enterprise that is market-oriented and realizes industrial development through R&D inno‌vation and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug approved by FDA≈ for Alzheimer's disease in the United States. Its treatment reaches the target dose anδd has low toxic and side effects. It has been widely ↕recognized by our medical community, and good tolerance is its big≥gest advantage. In October 1999, Donepezil was launched in China und​er the trade name "Aricept", which is the main chemical drug aga>inst Alzheimer's disease. At present, CFDA has approvλed a number of domestic enterprises to produce donepezil preparations, the main dosage forms are ​tablets, capsules, dispersive tablets, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eli≥quis, Bristol-Myers Squibb/Pfizer), a direct oral factor Xa inhibitor, was approved f§or use in the 27 EU member states. The world's first drug approved to prevent venous t>hromboembolism (VTE) in adult patients undergoing elective hip or knee r✘eplacement. From June 2019 to June 2020, the annual sales of apixaban products overseas reached aboβut $15.4 billion, with a year-on-year growth of nearly 32%, γand the API consumption reached about 23,960 kg, with a year-on-year growth of about 28%. Compa÷red with its main competitor, Rivaroxaban, the drug's annual overseas sal es are about $4.5 billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise tha→t is market-oriented and realizes industrial development through R&D innovation and technolog≈y transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured b£y Genzyme. On December 29, 2004, it was approved by FDA for the treatment of refractory or r€elapsed acute lymphoblastic leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceut₹ical enterprise that is market-oriented and realizes industrial development through R&Dσ innovation and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If you need other services, E-→mail: 2880705932@qq.com

Copyright © 2022 Anhui Union Pharmaceuticals Technology Co., Ltd.